We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$426M
AUM Growth
+$11.7M
Cap. Flow
-$16M
Cap. Flow %
-3.75%
Top 10 Hldgs %
28.75%
Holding
218
New
10
Increased
59
Reduced
78
Closed
10

Top Buys

Rank Stock Value
1
AIG icon
American International
AIG
+$7.81M
2
BID
Sotheby's
BID
+$6.1M
3
VTR icon
Ventas
VTR
+$5.94M
4
DNOW icon
DNOW Inc
DNOW
+$1.08M
5
GNC
GNC Holdings, Inc.
GNC
+$853K

Sector Composition

Rank Sector Weight
1 Miscellaneous 14.87%
2 Healthcare 14.56%
3 Financials 14.11%
4 Industrials 12.33%
5 Communication Services 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$4.19T
$14.3M 3.36%
494,915
-8,605
-2% -$233K
CMCSA icon
2
Comcast
CMCSA
$96B
$12.8M 3.01%
478,542
-34,862
-7% -$896K
NSC icon
3
Norfolk Southern
NSC
$78.3B
$12M 2.81%
116,169
-672
-0.6% -$65.9K
BHC icon
4
Bausch Health
BHC
$2.36B
$11.7M 2.76%
93,131
+1,223
+1% +$156K
QCOM icon
5
Qualcomm
QCOM
$175B
$11.7M 2.76%
148,312
-1,002
-0.7% -$79.7K
TFCFA
6
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$10.9M 2.55%
308,728
-1,491
-0.5% -$50.7K
ESRX
7
DELISTED
Express Scripts Holding Company
ESRX
$10.8M 2.54%
155,929
+3,161
+2% +$222K
AGN
8
DELISTED
Allergan plc
AGN
$10.8M 2.54%
48,451
+3,946
+9% +$817K
V icon
9
Visa
V
$712B
$10.7M 2.51%
202,660
-12,608
-6% -$659K
NOV icon
10
NOV
NOV
$7.48B
$10.4M 2.45%
126,605
-12,812
-9% -$954K
XOM icon
11
ExxonMobil
XOM
$644B
$9.47M 2.22%
94,093
+2,521
+3% +$254K
BNY
12
Bank of New York Mellon
BNY
$110B
$9.21M 2.16%
245,625
-2,704
-1% -$93.6K
TD icon
13
Toronto Dominion Bank
TD
$199B
$9.12M 2.14%
177,458
-1,986
-1% -$96.4K
AIG icon
14
American International
AIG
$40.2B
$8.9M 2.09%
162,988
+147,593
+959% +$7.81M
CSX icon
15
CSX Corp
CSX
$95B
$8.84M 2.07%
860,541
-7,218
-0.8% -$70.3K
DTV
16
DELISTED
DIRECTV COM STK (DE)
DTV
$7.93M 1.86%
93,260
-88,981
-49% -$7.25M
JNJ icon
17
Johnson & Johnson
JNJ
$646B
$7.38M 1.73%
70,590
+19
+0% +$1.92K
AFL icon
18
Aflac
AFL
$58.4B
$7.34M 1.72%
235,992
-2,568
-1% -$80.1K
SBS icon
19
Sabesp
SBS
$17.1B
$6.64M 1.56%
3,194,198
-8,054
-0.3% -$15.4K
GNC
20
DELISTED
GNC Holdings, Inc.
GNC
$6.47M 1.52%
189,753
+21,423
+13% +$853K
ACN icon
21
Accenture
ACN
$116B
$6.33M 1.49%
78,295
-2,384
-3% -$191K
BID
22
DELISTED
Sotheby's
BID
$6.29M 1.48%
+149,909
New +$6.1M
DOC icon
23
Healthpeak Properties
DOC
$14.5B
$5.97M 1.4%
158,524
-1,709
-1% -$64.3K
PEP icon
24
PepsiCo
PEP
$193B
$5.94M 1.39%
66,439
-265
-0.4% -$22.9K
VTR icon
25
Ventas
VTR
$47.1B
$5.85M 1.37%
+79,961
New +$5.94M

Similar funds

M&R Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, M&R Capital Management held 218 positions worth $426M, up 2.8% from $414M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

M&R Capital Management withdrew a net $16M in Q2 2014, closing 10 positions and reducing 78 holdings. Its most notable exit was Zimmer Biomet, an estimated $1.19M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, M&R Capital Management opened a new position in Sotheby's worth $6.29M.

  • M&R Capital Management's largest Q2 2014 buy was Sotheby's: 149,909 shares worth $6.29M.
  • M&R Capital Management added most to American International in Q2 2014, an estimated $7.81M increase.
  • M&R Capital Management's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $9.15M.
  • M&R Capital Management fully exited Zimmer Biomet in Q2 2014, selling an estimated $1.19M.
  • M&R Capital Management's ten largest holdings make up 29% of its $426M portfolio in Q2 2014.
  • M&R Capital Management opened 10 new positions and closed 10 in Q2 2014.
  • M&R Capital Management's portfolio value rose 2.8% quarter-over-quarter to $426M.

Based on M&R Capital Management's 13F filing for Q2 2014, filed 11 Aug 2014.